CPT-01

N/A

Report date: 2022/12/29 16:40:09
NME

Base Information

Drug NameCPT-01
Drug Alias NameCPT-01
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTriple Negative Breast NeoplasmsLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Wosheng Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Wosheng Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A